Sixteen Healthcare Groups Make Major Commitments at 2nd Annual Patient Safety Rally in Taiwan
The Patient Safety Movement Foundation (PSMF) joined the Taiwan Patient Safety Culture Club (TPSCC) at the 2nd Annual Patient Safety Rally hosted by the TPSCC in Taichung, Taiwan on April 21, 2018. Sixteen healthcare organizations, including fourteen hospitals, committed to implementing the PSMF’s evidence-based Actionable Patient Safety Solutions (APSS), which have been proven to improve healthcare quality and eliminate preventable harm, and deaths, in hospitals.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180423005360/en/
More than 150 attendees, including hospital executives and staff, attended this year's 2nd Annual Patient Safety Rally in Taiwan (Photo: Business Wire)
“I’ve said before that we must not hope for zero preventable patient deaths, we must plan for zero. We are thrilled by the leadership of Dr. Mingi Chan Liao M.D., Ph.D. and the Taiwan Patient Safety Culture Club who have rallied Taiwan’s hospitals to act on behalf of patients everywhere. Only through action will we be able to eliminate preventable harm from hospitals,” explained Joe Kiani, Founder, and Chairman of the Patient Safety Movement.
At the rally, Joe Kiani welcomed attendees with a short video. Each hospital’s leadership and executive staff took the stage to publicly announce their commitments to implement the APSS that, when implemented, will positively improve the care provided in their facilities. The list of committed hospitals and partners include:
1. Taichung Armed Forces General Hospital
2. Taitung Hospital
3. Chiayi Branch, Taichung Veterans General Hospital
4. Ministry of Health and Welfare Pingtung Hospital
5. Keelung Hospital Ministry of Health and Welfare
6. Taipei Hospital, Ministry of Health and Welfare
7. Jianan Psychiatric Center, Ministry of Health and Welfare
8. Hua-lien Hospital, Ministry of Health and Welfare
9. Pingtung Christian Hospital
10. St. Joseph’s Hospital
11. Tung's Taichung MetroHarbor Hospital
12. Penghu Hospital, Ministry of Health and Welfare
13. Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
14. Changhua Christian Children’s Hospital
15. Committed Partner: Taiwan Healthcare Quality Association
16. Committed Partner: Unison Healthcare Group
Also speaking at the rally were Ms. Maria Cvach, the director of Policy Management and Integration at Johns Hopkins Hospital and Dr. Shin Ushiro, a professor of safety management at Kyushu University Hospital, Japan. The Patient Safety Movement Foundation’s Vice President, Ariana Longley, was on hand to support the work being done by the TPSCC, as one of the PSMF’s most active committed partners internationally. More than 120 supporters attended the rally as the Taiwan Patient Safety Culture Club works to join the PSMF in unifying the healthcare ecosystem.
“To improve patient safety, we must not only listen but act. I am thrilled by the commitment of all sixteen committed hospitals and partners who have shown great leadership by implementing evidence-based processes proven to improve patient safety. The combined commitments from our two rallies means that 19 out of 22 administrative regions have embraced patient safety with the commitment to ZERO preventable deaths by 2020,” explained Dr. Chan Liao.
Following the rally, Ms. Longley joined the Club’s President, Dr. Chan Liao, for visits to local hospitals. The rally is the second in the last year by Taiwan’s hospitals to raise awareness and take action to improve patient safety in hospitals. Last year, 19 Taiwanese hospitals made commitments to implementing APSS.
For more information on the rally or the Patient Safety Movement Foundation, please visit patientsafetymovement.org or contact Tanya Lyon, Public Relations Manager at (949) 351-2858 or email@example.com.
About Patient Safety Movement Foundation:
More than 200,000 U.S. patients and three million worldwide die each year from preventable causes. The Patient Safety Movement Foundation (PSMF) was established through the support of the Masimo Foundation for Ethics, Innovation, and Competition in Healthcare to reduce that number of preventable deaths to zero by 2020 (0X2020). Improving patient safety requires a collaborative effort from all stakeholders, including patients, healthcare providers, medical technology companies, government, employers, and private payers. The PSMF works with all stakeholders to address problems with actionable solutions. The Foundation also convenes the World Patient Safety, Science and Technology Summit bringing together some of the world’s best minds for thought-provoking discussions and new ideas that challenge the status quo. By presenting specific, high-impact solutions to meet patient safety challenges, called Actionable Patient Safety Solutions, encouraging medical technology companies to share the data their products are purchased for, and asking hospitals to make commitments to implement Actionable Patient Safety Solutions, the Patient Safety Movement Foundation is working toward zero preventable deaths by 2020. Visit http://patientsafetymovement.org/.
Patient Safety Movement Foundation
Tanya Lyon, 949-351-2858
Public Relations Manager
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Takeda to Present Positive Data from ALUNBRIG® (brigatinib) ALTA-1L Trial Showing a Reduction in Risk of Disease Progression or Death of More Than 50 Percent Versus Crizotinib in First-Line Advanced ALK+ NSCLC25.9.2018 12:32 | Pressemelding
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced results from the Phase 3 ALTA-1L (ALK in Lung Cancer Trial of BrigAtinib in 1 st Line) trial, demonstrating that ALUNBRIG reduced the risk of disease progression or death, known as progression-free survival (PFS), as assessed by a blinded independent review committee (BIRC), by more than fifty percent compared to crizotinib in adults with anaplastic lymphoma kinase-positive (ALK+) locally advanced or metastatic non-small cell lung cancer (NSCLC) who had not received a prior ALK inhibitor. Findings from the first interim analysis of the ALTA-1L trial will be presented during the Presidential Symposium at the International Association for the Study of Lung Cancer (IASLC) 19th World Conference on Lung Cancer (WCLC) in Toronto on Tuesday, September 25, 2018. The data were also simultaneously published online in The New England Journal of Medicine. ALUNBRIG is currently not approved as first-line therapy for advanced ALK+ NSC
Softomotive and Enate Partner to Help Clients Orchestrate Workflows across Their RPA Ecosystem25.9.2018 12:15 | Pressemelding
Softomotive, a leading Robotic Process Automation (RPA) vendor, has announced a strategic partnership with Enate, the pioneering Robotic Service Orchestration (RSO) provider. Together, Softomotive and Enate will allow business enterprises of all sizes to go further and faster with their automation programmes, achieving greater efficiency through orchestration of workflows between human employees and software robots. This partnership will offer Softomotive and Enate’s mutual customers the flexibility to orchestrate workflow between humans and bots whether the enterprise is using just Softomotive bots or more than one RPA provider. “As the RPA market matures, we are finding more and more clients are relying on more than one RPA provider, ” said Marios Stavropoulos, Softomotive’s CEO. “This adds an extra layer of complexity and Softomotive is all about simplifying things for our clients. This new partnership with Enate will do just that by allowing them to continue to orchestrate combined
Scientist.com Adds Experienced Drug Hunter Mark Herbert to Management Team25.9.2018 12:06 | Pressemelding
Scientist.com, the life science industry’s leading online marketplace for outsourced research, announced today the appointment of Mark Herbert to its senior leadership team. As the company’s chief business officer, he will focus on continuing the company’s rapid growth and expansion into new research areas and countries. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180925005077/en/ Scientist-entrepreneur Mark Herbert brings his strong scientific background and business experience to Scientist.com as new Chief Business Officer. (Photo: Business Wire) “The Scientist.com research sourcing platform is revolutionizing how medical research is done,” said Mark Herbert, Scientist.com’s new Chief Business Officer. “I look forward to helping establish new partnerships, expand existing partnerships and advance our goal of delivering an innovative and disruptive marketplace to the global life sciences community.” Mark has 20+ years’ e
OpenGate Capital Signs Exclusivity Agreement to Sell NAKAN to Westlake Chemical Corporation25.9.2018 12:00 | Pressemelding
OpenGate Capital, a global private equity firm, announced today that it has signed an exclusivity agreement with Westlake Chemical Corporation (NYSE: WLK), pursuant to which Westlake has made a binding offer to acquire NAKAN, a global PVC compounding solutions business headquartered in Reims, France. The transaction is valued at $265 million and is anticipated to be completed by early 2019. NAKAN has eight production facilities located in China, France, Germany, Italy, Japan, Mexico, Spain and Vietnam, as well as a world-class research facility in France and application laboratory in the United States. NAKAN products are used in a wide-variety of applications by customers in the automotive, building and construction, and medical industries. OpenGate Capital acquired NAKAN in 2015, through the acquisition of Ivy Group, during the firm’s pre-fund, legacy investment period. Ivy Group, formerly known as Kem One Innovative Vinyls, was acquired through a French administration process that or
The 2018 IDN World Report Findings Show Negative IDN Growth in 201725.9.2018 11:24 | Pressemelding
The 2018 IDN World Report findings have been published to idnworldreport.eu. The major findings from the report are: As at December 2017, 7.5 million IDNs were registered, a drop of 14% since December 2016. A major factor in the reduction in global IDN numbers was a change of policy by the Vietnam ccTLD, which resulted in a loss of nearly 1 million .vn second level IDNs. Excluding the impact of .vn, the underlying trend is negative growth of -5%, distributed mainly across second level ccTLDs. IDNs comprise 2% of the world’s domains, a percentage that has remained fairly static since at least 2012. The data in this report include IDNs across both ccTLDs and gTLDs, both at the first and second level. Distribution patterns of IDN registrations are different from those of traditional, ASCII domain names. IDN registrations are highest in Asia and Pacific region. The script of IDNs registered throughout the world strongly correlate to the languages spoken in different countries and territori
Michael Kors Holdings Limited to Be Renamed Capri Holdings Limited25.9.2018 11:00 | Pressemelding
Michael Kors Holdings Limited (NYSE:KORS), a global fashion luxury group, announced today that a definitive agreement has been signed to acquire all of the outstanding shares of Italian luxury fashion house Gianni Versace S.p.A. for a total enterprise value of Euro 1.83 billion or approximately US$2.12 billion. Versace, long recognized as one of the world’s leading luxury fashion companies, is synonymous with Italian glamour and style. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180925005557/en/ L-R: Jonathan Akeroyd, Donatella Versace, John D. Idol. (Photo: Rahi Rezvani) John D. Idol, Chairman and Chief Executive Officer of Michael Kors Holdings Limited, said, “The acquisition of Versace is an important milestone for our group. Versace was founded in 1978. For over 40 years, Versace has represented the epitome of Italian fashion luxury, a testament to the brand’s timeless heritage. We are excited to have Versace as part